Example: Heart Attack

Search clinical trials for: Retinamide

Total 9 results





    • NCT04234048
      Not yet recruiting
      Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
      Conditions: T-cell Lymphoma; Cutaneous/Peripheral T-Cell Lymphoma; Peripheral T-cell Lymphoma; Peripheral T-Cell Lymphoma, Not Classified; Primary Cutaneous T-cell Lymphoma; Cutaneous T-Cell Lymphoma, Unspecified; Cutaneous T-cell Lymphoma; Follicular T-Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Sézary's Disease; Mycosis Fungoides
    • NCT02495415
      Recruiting
      Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas
      Conditions: Peripheral T-cell Lymphoma
    • NCT01535157
      Terminated
      Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer
      Conditions: Ovarian Cancer; Cancer of Ovary; Cancer of the Ovary; Ovary Neoplasms; Primary Peritoneal Carcinoma
    • NCT01187810
      Completed
      Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL
      Conditions: Acute Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Non-Hodgkin's Lymphoma
    • NCT00003223
      Terminated
      SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth
      Conditions: Head and Neck Cancer
    • NCT00003099
      Completed
      Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer
      Conditions: Breast Cancer
    • NCT00004161
      Completed
      Fenretinide in Treating Patients With Leukoplakia of the Mouth
      Conditions: Head and Neck Cancer
    • NCT00003075
      Completed
      Fenretinide in Treating Patients With Cervical Neoplasia
      Conditions: Cervical Cancer; Precancerous Condition
    • NCT00001378
      Completed
      A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer
      Conditions: Breast Cancer; Breast Neoplasms
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations